Recombinant CD38 (Daratumumab Biosimilar) antibody

Catalog No. ABIN7581292

The Human Monoclonal anti-CD38 (Daratumumab Biosimilar) antibody has been validated for FACS, ELISA, BLI, Func and SPR. It is suitable to detect CD38 (Daratumumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD38 (Daratumumab Biosimilar) antibody (ABIN7581292)

Target: CD38 (Daratumumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD38 (Daratumumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD38 (Daratumumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD38 Reference Antibody (daratumumab)

Characteristics: Anti-CD38 Reference Antibody (daratumumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.34 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Conditions: Multiple Myeloma

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD38 (Daratumumab Biosimilar)

Target: CD38 (Daratumumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: cADPr hydrolase 1, T10

Molecular Weight: 145.34 kDa

UniProt: P28907